A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
Unlock the market timeline & signal feed
71 signals in the last 90 days.
The order this company entered each market — oldest to newest
11 active postings
19 active postings
Sign up to see the full signal feed
How Beckman Coulter Diagnostics's international expansion compares to its competitors
Beckman Coulter DiagnosticsYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Beckman Coulter DiagnosticsYou | 26 | 1 | +40% | 60 | 34 |
Technician Production Operations (Night Shift)
View postingCounty Clare, Ireland · yesterday
Senior Analyst- Accounting
View postingMishima, Shizuoka, Japan · 3d ago
Accounting & Tax Manager Brazil
View postingSão Paulo, São Paulo, Brazil · 3d ago
ACCESS an IVD-quality platform to help advance your clinical trial strategy.
Active
Introducing neuro research testing’s answer key.
Active
Run your trials on the platform built for diagnostic success.
ActiveBeckman Coulter launches new RUO immunoassays for neurodegenerative disease research, detecting biomarkers p-Tau217, GFAP, NfL, and APOE ε4 on their automated high-throughput platform.
Market Research Center releases report on global lab automation in drug discovery market, covering market size, trends, forecasts, and key players through 2030.
Beckman Coulter Life Sciences announces local production of Avanti J series centrifuges in Suzhou, China, featuring three models (JXN-30, JXN-26, J-26S XP) with intelligent design, GLP/GMP compliance, and comprehensive biosafety features for research and biopharmaceutical applications.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Beckman Coulter Diagnostics's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
